Pharmaceutical formulation for aerosols, comprising two or more active agents and at least one surfactant

Details for Australian Patent Application No. 2007213819 (hide)

Owner Boehringer Ingelheim Pharma GmbH & Co. KG

Inventors Schmidt, Friedrich; Hoelz, Hubert; Berkel, Erhard

Agent Davies Collison Cave

Pub. Number AU-A-2007213819

PCT Pub. Number WO2007/090822

Priority 10 2006 053 374.7 10.11.06 DE; 10 2006 006 207.8 09.02.06 DE

Filing date 6 February 2007

Wipo publication date 16 August 2007

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

Event Publications

2 October 2008 PCT application entered the National Phase

  PCT publication WO2007/090822 Priority application(s): WO2007/090822

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007213821-Guide rail comprising a rapid fixing device

2007213804-Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products